Results 71 to 80 of about 1,738 (148)

Healthcare Resource Utilization and Costs in Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Leukemia Treated With Covalent Bruton's Tyrosine Kinase Inhibitors: Real-World Impact of Cardiovascular Adverse Events. [PDF]

Cancer Med
Obeng-Kusi M, De Nigris E, Leng S, Farooqui MZH, Yapici HO, Weimer I, Jiao W, Hyatt HW, Zhang X, Lodaya K, Dingli D.   +10 more
europepmc   +1 more source

Case Report: X-linked agammaglobulinemia with progressive neurodegeneration from immunological to neurological implications. [PDF]

Front Immunol
Chen X, Gu H, Piao Y, Ma Y, Zhao Y, Mao H, Wang Y, Deng J.   +7 more
europepmc   +1 more source

Resistance Mutations in CLL: Genetic Mechanisms Shaping the Future of Targeted Therapy. [PDF]

Genes (Basel)
Sekeres S, Lamkin EN, Bravo E, Cool A, Taylor J.   +4 more
europepmc   +1 more source

BTK autoinhibition analyzed by high-throughput swaps of SH2 domains. [PDF]

Proc Natl Acad Sci U S A
Eisen TJ, Ghaffari-Kashani S, Hung CL, Groves JT, Kuriyan J.   +4 more
europepmc   +1 more source

Human Pathogenic Mutations in Protein Domains [PDF]

, 2004
Lappalainen, Ilkka
core  

Case Report: dose adjustment of orelabrutinib for managing central nervous system post-transplant lymphoproliferative disorder following acute lymphoblastic leukemia transplantation. [PDF]

Front Immunol
Wang W, Chen J, Guan L.
europepmc   +1 more source

X-linked agammaglobulinemia presenting as polymicrobial pneumonia, including Pneumocystis jirovecii [PDF]

, 2014
Bonagura, V. R., Gough, J. D., Jongco, A. M., Moreau, J., Ponda, P., Rosenthal, D. W., Sarnataro, K.   +6 more
core   +3 more sources

Next-generation Bruton tyrosine kinase inhibitors and degraders in the treatment of B-cell malignancies: advances and challenges. [PDF]

Ann Hematol
Wang Y, Zhang Y, Liu J, Jiang Y, Li J, Shi W.   +5 more
europepmc   +1 more source

Bone marrow progenitor cells and vascular endothelium : Studies on the in vivo differentiation capacity and the role of Bmx tyrosine kinase [PDF]

, 2004
Rajantie, Iiro
core  

Microsecond simulations to investigate the structural mechanism of super-resistant double mutations in BTK to the covalent inhibitor ibrutinib in multiple leukemia. [PDF]

Sci Rep
Khan A, Ali SS, Zahid MA, Alshabrmi FM, Al-Zoubi RM, Shkoor M, Mohammmad A, Wei DQ, Agouni A.   +8 more
europepmc   +1 more source